Navigation Links
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
Date:3/31/2008

re attributable to common shareholders of $0.72 for the full year 2006 based on weighted average shares of approximately 2.6 million. The net loss per share attributable to common stockholders in all periods includes non-cash charges for accretion of preferred stock dividends and 2007 also includes the reversal of accreted preferred stock dividends and a deemed dividend on the conversion of preferred stock into common stock upon completion of the Company's initial public offering. The weighted average shares used in computing loss per share attributable to common shareholders excludes anti-dilutive securities such as stock options and warrants and also redeemable preferred stock in periods prior to their conversion to common stock upon completion of the Company's initial public offering.

Cost of product sales totaled $1.0 million and $3.5 million in the fourth quarter of 2007 and full year 2007, respectively. The cost of product sales was $0.2 million for the fourth quarter of 2006 and the full year 2006, as the Company acquired the urokinase product in April 2006 and commenced sales in October 2006. The cost of product sales includes the price paid to acquire the urokinase asset as well as labeling costs directly incurred in bringing the product to market.

Research and development expenses for the fourth quarter of 2007 decreased to $2.0 million from $2.6 million in the fourth quarter of 2006, primarily due to less outside contract work performed on grants and pre-clinical studies. Research and development expenses decreased to $7.4 million for the full year 2007 from $9.1 million for the full year 2006 as a result of staffing reductions, third party service costs and other expenses related to the Company's refined SonoLysis strategy. Full year 2006 results also included expenses related to recombinant thrombolytic drug assets relinquished to Abbott Laboratories in December 2006, which were partially offset by increased clinical trial expenses recorde
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
2. ImaRx to Report Corporate Updates and 4Q07 Financial Results
3. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
6. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
7. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
8. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
9. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
10. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
11. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 The ability for organizations ... that will allow individuals to perform at the highest ... for employers looking to compete in this post–recession era. ... this trend, as the sector increasingly focuses on the ... which will have real results on the organization's development ...
(Date:8/28/2014)... -- Next month, executives from clinical trial marketing firm BBK Worldwide ... Patient-Centered Clinical Trials 2014 , to be held at ... September 4-5. Patient recruitment experts Bonnie A. Brescia , ... share insights on the benefits of employing an effective patient ... media to mobile apps – can be used to drive ...
(Date:8/28/2014)... --  SunTrust Robinson Humphrey (STRH) today announced ... equity research team in biotechnology and oilfield services.  ... research demonstrates our commitment to providing our valued ... investment decision making," said Biff Woodruff , ... make significant investments in differentiated content at a ...
(Date:8/28/2014)... Sterlitech is proud to announce that ... stable of products . These additional products ... include membrane filters with surface charges. , ... for our membrane process testing equipment, and correspondingly, a ... membranes,” explains Sterlitech President Mark Spatz. “The addition ...
Breaking Biology Technology:Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3BBK Worldwide Leads Sessions at Key September Events 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Sterlitech Corporation Enhances Its Selection of Flat Sheet Membrane Filters 2
... has implemented IBM s eServer BladeCenter JS20 as ... proteomics research. IBM announced last month the BladeCenter JS20 ... will begin shipping in volume globally in April 2004. ... Sequest application on the JS20 running SUSE LINUX. Sequest is ...
... the future workforce have recently been issued by the ... think tanks on economic, political and social issues. Both ... are about to change dramatically as a result of ... gain momentum. The result will be a vastly different ...
... Lithuania or Hong Kong what they know about Wisconsin, chances ... beer, brats, cheese or the Green Bay Packers. But how ... if anything. However, its vital to Wisconsins economic future that ... technology assets from its great research institutions to its ...
Cached Biology Technology:Medical College of Wisconsin enhances research with IBM Blade server 2Are you ready to play the new talent management game? 2Are you ready to play the new talent management game? 3When its parts pull together, Wisconsin can tell a compelling economic story 2
(Date:8/28/2014)... Dyslexia, the most commonly diagnosed learning disability ... disability that occurs when the regions of the ... , The use of non-invasive functional neuroimaging tools ... in dyslexia. However, most prior work has focused ... leaving a gap in our understanding of how ...
(Date:8/28/2014)... of new roads will be built worldwide by 2050. ... wildernesses, where they bring an influx of destructive loggers, ... study has created a ,global roadmap, for prioritising road ... competing demands of development and environmental protection. , The ... that natural importance of ecosystems and a ,road-benefits, layer ...
(Date:8/28/2014)... . Cars, planes ... of sophisticated assembly lines. Mobile assembly carriers, on to which ... assembly lines. In the case of a car body, the ... a precise spatial and chronological sequence, resulting in a complete ... of such an assembly line at molecular level has been ...
Breaking Biology News(10 mins):Dyslexic readers have disrupted network connections in the brain 2Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Nanoscale assembly line 2Nanoscale assembly line 3
... German . What happens if you cannot recall ... name and face of a person, yet you might be unable ... the recall of the information is temporarily impaired. How such associative ... great mysteries of modern neurobiology. Now, scientists from the Max Planck ...
... basis of the most pessimistic and severe scenarios for conditions ... 2080, the oak woods of the Basque Country ... habitat, given that, in our territory, wooded areas will not ... development. Neiker-Tecnalia experts consider that this study illustrates the tendency ...
... scombrids (tunas, bonitos, mackerels and Spanish mackerels) and billfishes ... Red List of Threatened SpeciesTM. Of the 61 known ... at serious risk of extinction. Four species are listed ... in the Least Concern category. The results show ...
Cached Biology News:How memory is read out in the fly brain 2How memory is read out in the fly brain 3Climate change may alter conditions for growth of oak trees in Euskadi 2Increased protection urgently needed for tunas 2Increased protection urgently needed for tunas 3
... be upgraded to the GenePix Autoloader 4200AL. ... and saves results for up to 36 ... the batch is complete. Line-by-line autofocus ensures ... GenePix Pro gives you complete flexibility to ...
... Maximize the value of your microarray data ... support you need from consultation to extensive ... date methods. Utilize our expertise in combination ... from your own microarray experiments., ,Normalization and ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Biology Products: